TSI Group Co

TSI Group Co AAQS

The The AAQS of TSI Group Co (603262.SS) as of Oct 21, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

TSI Group Co has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock TSI Group Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The TSI Group Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2022
4.00 CNY
Jan 1, 2023
4.00 CNY
Jan 1, 2024
4.00 CNY
The TSI Group Co AAQS history
YEARAAQSYoY
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TSI Group Co Stock analysis

What does TSI Group Co do? TSI Group Co., Ltd. generates revenue through the research, development, and manufacturing of dietary nutritional supplements, primarily selling nutritional raw materials like β-hydroxy β-methyl butyrate (HMB), glucosamine, and chondroitin sulfate, as well as finished products such as tablets and hard capsules. The company markets its branded products under myHMB and GlucosaGreen, targeting both domestic and international consumers through its global distribution channels. Its main customers include health supplement retailers, pharmaceutical companies, and wellness brands that purchase raw materials and finished formulations for their own product lines. TSI Group's product portfolio focuses on high-demand nutritional ingredients, with HMB, glucosamine, and chondroitin sulfate serving as core offerings for sports nutrition and joint health applications. The myHMB brand specifically emphasizes muscle support, while GlucosaGreen targets joint care, aligning with consumer trends in functional nutrition. The company's domestic market presence complements its overseas sales, leveraging its Shanghai headquarters for global operations. The firm's revenue streams are driven by B2B transactions with manufacturers and retailers, as well as direct sales of branded supplements to end consumers in key markets. By maintaining a dual focus on raw material supply and branded consumer products, TSI Group captures value across the nutritional supplement supply chain, from ingredient sourcing to final product delivery. TSI Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TSI Group Co stock

The AAQS of TSI Group Co is 4 in 2024.

On Eulerpool you can find the complete historical development of The AAQS TSI Group Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — TSI Group Co

All Key Metrics — TSI Group Co